Para ordenar a las Comisiones de Salud; y de Desarrollo Económico, Pequeños Negocios, Banca, Comercio, Seguros y Cooperativismo del Senado de Puerto Rico a realizar una investigación exhaustiva sobre las disposiciones relacionadas con la protección del criterio médico y el acceso inmediato a medicamentos recetados contenidas en la Ley 142-2020, así como analizar el impacto de la determinación judicial de invalidez de dicha Ley, a los fines de proponer medidas legislativas prospectivas, correctivas o sustitutivas.

2025-2028 Session

Directs key committees to review Law No. 142-2020’s compliance, medical-judgment protections, and access to medications, and to propose corrective or substitute measures.

Referido a Comisión(es)

Summary: Bill RS 341 (Puerto Rico Senate)

Overview

Bill RS 341 is a Senate resolution introduced on October 16, 2025, directing specific Senate committees to conduct a comprehensive investigation into the compliance, implementation, and current status of Law No. 142-2020. The investigation would cover the law’s mandate, provisions protecting medical judgment, and access to prescribed medications, as well as the effects of any judicial annulment of the law. The goal is to propose prospective, corrective, or substitute legislative measures based on the findings. The bill is categorized as a resolution and is currently referred to committee(s).

Purpose and Intent

To require a thorough review of Law No. 142-2020 by the Senate.

To assess whether the law’s mandates regarding medical judgment protection and immediate access to prescribed medications are being fulfilled.

To analyze the consequences of any court-ordered nullification or annulment related to the law.

To identify gaps or issues and to recommend legislative remedies or new measures.

Key Provisions and Scope

Directs the following Senate committees to lead the investigation:

Comisión de Salud (Health Committee)
Comisión de Desarrollo Económico, Pequeños Negocios, Banca, Comercio, Seguros y Cooperativismo (Committee on Economic Development, Small Businesses, Banking, Trade, Insurance, and Cooperativism)

Requires an exhaustive examination of:

Compliance with Law No. 142-2020 and the law’s stated mandate.
The protection of medical judgment as provided by the law.
Access to immediate prescribed medications.
The impact and implications of any judicial annulment related to the law.

Aims to evaluate all aspects of Law No. 142-2020 to inform future legislative actions, including prospective, corrective, or substitute measures.

Affected Parties and Impacts

Affects healthcare policy and administration in Puerto Rico, including:

Healthcare providers (physicians, clinics, hospitals)
Pharmacists and pharmacies
Patients relying on prescribed medications
Government health agencies administering or enforcing Law No. 142-2020
Payers and insurers impacted by access and coverage provisions

The resolution could lead to amendments to Law No. 142-2020 or to new related legislation, depending on findings.

Procedural and Timeline Aspects

Status: Referido a Comisión(es) (referred to committees).

Legislative Actions:

Radicado: October 16, 2025
Primera Lectura: October 20, 2025
Referido a Comisión(es): October 20, 2025

As a resolution, the bill seeks to produce a report and recommendations rather than enact immediate statutory changes; any policy changes would proceed through subsequent legislative steps based on the investigation’s findings.

Next Steps

Committee review and hearings to gather evidence, testimony, and data on Law No. 142-2020.

Development of findings and formal recommendations.

Potential introduction of corrective or substitute legislation in a future session if warranted by the investigation.